Castle Biosciences (CSTL)
(Delayed Data from NSDQ)
$22.15 USD
+0.87 (4.09%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $22.12 -0.03 (-0.14%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/1/24 |
---|---|
Current Quarter | -0.37 |
EPS Last Quarter | -0.10 |
Last EPS Surprise | 88.10% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.01 |
Next Year | -1.78 |
EPS (TTM) | -2.16 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 68.34M | 53.57M | 237.48M | 259.70M |
# of Estimates | 1 | 1 | 1 | 2 |
High Estimate | 68.34M | 53.57M | 237.48M | 260.00M |
Low Estimate | 68.34M | 53.57M | 237.48M | 259.40M |
Year ago Sales | 42.04M | 50.14M | 219.79M | 237.48M |
Year over Year Growth Est. | 62.56% | 6.84% | 8.05% | 9.36% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.37 | -0.76 | -3.01 | -1.78 |
# of Estimates | 1 | 1 | 2 | 1 |
Most Recent Consensus | -0.37 | -0.76 | -2.32 | -1.78 |
High Estimate | -0.37 | -0.76 | -2.32 | -1.78 |
Low Estimate | -0.37 | -0.76 | -3.70 | -1.78 |
Year ago EPS | -1.10 | -0.70 | -2.14 | -3.01 |
Year over Year Growth Est. | 66.36% | -8.57% | -40.65% | 40.86% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 0 | 1 | 0 |
Up Last 60 Days | 1 | 0 | 2 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 0 | 1 |
Down Last 60 Days | 0 | 1 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.37 | -0.76 | -3.01 | -1.78 |
7 Days Ago | -0.37 | -0.76 | -3.01 | -1.78 |
30 Days Ago | -0.82 | -0.75 | -2.99 | -1.20 |
60 Days Ago | -0.82 | -0.75 | -3.03 | -1.20 |
90 Days Ago | -0.79 | -0.73 | -3.00 | -1.21 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.37 | -0.76 | -2.32 | -1.78 |
Zacks Consensus Estimate | -0.37 | -0.76 | -3.01 | -1.78 |
Earnings ESP | 0.00% | 0.00% | 22.92% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.10 | -0.26 | -0.70 | -1.10 | NA |
Estimate | -0.84 | -0.92 | -1.01 | -0.80 | NA |
Difference | 0.74 | 0.66 | 0.31 | -0.30 | 0.35 |
Surprise | 88.10% | 71.74% | 30.69% | -37.50% | 38.26% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more